Teva Pharmaceutical Industries (NYSE:TEVA) Update / Briefing September 22, 2025 11:00 AM ET Company ParticipantsLes Sulewski - VP, Biotech Equity ResearchMatthew Toal - AssociateChristopher Stevo - SVP,Head of Investor RelationsEric Hughes - EVP Global R&D and Chief Medical OfficerChris Fox - EVP US CommercialChristoph Correll - Professor of Psychiatry and Chair of Child & Adolescent PsychiatryConference Call ParticipantsJason Gerberry - Managing Director and Equity Research AnalystDavid Amsellem - Managing ...